- Home
- XAGE
XAGE
LONGEVITY HEALTH HLDGS INC
as 05-23-2025 4:00pm EST
Stocks
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | PITTSBURGH |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.29 - $87.90 | Next Earning Date: | 05-15-2025 |
| Revenue: | $560,671 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest LONGEVITY HEALTH HLDGS INC News
XAGE Breaking Stock News: Dive into XAGE Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
GlobeNewswire
9 days ago
Longevity Health Holdings Announces Business Updates
GlobeNewswire
12 days ago
Longevity Health Holdings, Inc. Announces Reverse Stock Split
GlobeNewswire
a month ago
Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs
Compare XAGE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XAGE LONGEVITY HEALTH HLDGS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.